RxDoctor Payments Data

Adam Bodian, MD

Procedural Dermatology · Great Neck, NYNPI 1518033687

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,302 of the $11,534 with a category attached, or 80.6%. 29 manufacturers reported payments, led by AbbVie at 33.7% of the total. Reporting peaked in 2022 at $3,095 and has fallen 59.8% since, to $1,245 in 2025.

$11,534in general payments, 2019–2025

Across 476 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Johnson & Johnson$930
  • Novartis$803
  • Lilly USA, LLC$796
  • Merz North America, Inc.$784
  • Sanofi$552
  • plus $4K from 23 others

What the payments were for

  • Consulting fees$1,87516%
  • Food & beverage$9,30281%
  • Education$3573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,534 in reported general payments places this provider in the 65th percentile of 69 procedural dermatology providers in New York.

See all procedural dermatology providers in New York

Medicare billing

Part B allowed, 2024
$461,602
Medicare patients
1,066
Services billed
5,071

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate47$1,977
Fluorouracil35$1,856
Triamcinolone Acetonide108$1,450
Ketoconazole51$1,033
Doxycycline Hyclate46$804
CiclopiroxCiclopirox Olamine36$638
Minoxidil60$410
Hydrocortisone44$371
Mupirocin38$239
ValacyclovirValacyclovir Hcl12$187
MethotrexateMethotrexate Sodium13$158
Prednisone12$36

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Great Neck

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →